Scilex Pharmaceuticals Inc. – Trademark Portfolio
Entity Type: 03
Scilex Pharmaceuticals Inc. holds 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 11 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 3 trademarks are registered and 1 is pending. Notable registered marks include SCILEX, ZTLIDO, and RESPONSIBLE BY DESIGN. The owner is based in Malvern, PA.
301 Lindenwood Drive Suite 300
Malvern, PA 19355
Showing of trademarks Trademarks
Trademark Classifications
Scilex Pharmaceuticals Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Scilex Pharmaceuticals Inc. have?
Scilex Pharmaceuticals Inc. has 13 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 pending, 9 abandoned.
What trademark classes does Scilex Pharmaceuticals Inc. file in?
Scilex Pharmaceuticals Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Scilex Pharmaceuticals Inc.'s most well-known trademarks?
Scilex Pharmaceuticals Inc.'s registered trademark portfolio includes well-known marks such as SCILEX, ZTLIDO, and RESPONSIBLE BY DESIGN. These are among 3 currently registered trademarks in the portfolio.
What is Scilex Pharmaceuticals Inc.'s trademark registration success rate?
Scilex Pharmaceuticals Inc. has a 25% trademark registration rate, with 3 out of 12 resolved applications resulting in successful registration. Currently, 1 application is pending review.